Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Annex
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 11, 2021
October 28, 2021
5379f689-7e71-423b-b00d-e8c8654bbd0b
Related Documents
Bispecific Antibody Development Programs Guidance for Industry
Guidance DocumentMay 24, 2021Center for Drug Evaluation and Research
Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Guidance for Industry: Guidance for Industry
Guidance DocumentMay 11, 2021Center for Drug Evaluation and Research
S5(R3) Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals : Guidance for Industry
Guidance DocumentMay 11, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox